USEPA's PCB Bulk Product Waste Reinterpretation – 40 CFR Part 761

23 May 2013 Dashboard Insights Blog

The following post is provided by our guest author, Graham Crockford from TRC Environmental Corporation. 

PCBs were domestically manufactured from 1929 until their manufacture was banned in the United States in 1979. Due to their non-flammability, chemical stability, high boiling point, and electrical insulating properties, PCBs were used in hundreds of industrial and commercial applications resulting in legacy PCB issues at older manufacturing facilities. Some applications included electrical, heat transfer, sealing vacuum furnaces, hydraulic equipment (e.g., stamping presses); as well as plasticizers in paints, plastics, and rubber products. 

As market conditions and business needs change, the manufacturing sector is often faced with the need to expeditiously retrofit or expand manufacturing operations in certain locations, while needing to decommission manufacturing operations in others. Decommission or retrofitting of these older manufacturing facilities often result in the identification of legacy PCB issues which can be costly and time consuming to manage. On October 24, 2012, the USEPA issued the finalized PCB Bulk Product Waste Reinterpretation memorandum which allows for more straightforward and quicker removal and disposal of PCB-contaminated building materials.

Previous Interpretation - Under the previous interpretation, PCB remediation waste is waste containing PCBs as a result of a spill or release (date and concentration limits apply), e.g., PCB-contaminated soil, sediments, and concrete. Prior to reinterpretation, remediation waste was subject to stricter disposal requirements, such as disposal in TSCA chemical waste landfills; however, PCB bulk product waste was held to a different standard for disposal. PCB bulk product waste is derived from products manufactured to contain PCBs in a non-liquid state at 50 ppm or greater. Typical examples of bulk products are caulk, paint, and sealants. Because the cleanup and disposal requirements for PCB remediation waste and bulk product waste are different, the requirements to manage and dispose of these materials was complicated and costly. 

October 24, 2012 Reinterpretation – The USEPA reinterpretation means that the disposal options for masonry are the same as for the attached PCB caulk and ensure that building materials contaminated with PCBs have disposal options that remain protective while being more efficient and straightforward. The reinterpretation allows building material “coated or serviced” with PCB bulk product waste at the time of designation for disposal to be managed as a PCB bulk product waste rather than PCB remediation waste. This distinction is important as it can provide greater flexibility for determining appropriate cleanup requirements and disposal options for demolition materials. An illustration of the significance of this reinterpretation is found at the USEPA’s PCB Guidance Reinterpretation website. This reinterpretation was developed to allow for accelerated cleanups of PCB-contaminated building material by providing a more straightforward path for disposal pursuant to the PCB regulations.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.

Related Services

Insights

RCE PTA Carve-Out Resumes After Interference
18 September 2019
PharmaPatents
The Ninth Circuit Expected to Rule that Doctors Can Be Wrong in the Winter v. Gardens False Claims Act Case
18 September 2019
Legal News: Government Enforcement Defense & Investigations
Upcoming Webinar: Maximizing Solar Tax Credits - Navigating the Start of Construction Rules (Part 1)
17 September 2019
Renewable Energy Outlook
When Birds Finally Find a Nest
17 September 2019
Dashboard Insights
Lacktman, Ferrante Cited in mHealth Intelligence About Ryan Haight Act
19 September 2019
mHealth Intelligence
Tinnen Discusses How Viewpoint Diversity Helps Businesses Thrive
18 September 2019
InsideTrack
Vernaglia Comments on AHA v Azar Decision
18 September 2019
MedPage Today
Lach Comments on Launch of New Group
16 September 2019
BizTimes Milwaukee
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
BRG Healthcare Leadership Conference
06 December 2019
Washington, D.C.
CTeL Telehealth Fall Summit 2019
04-06 December 2019
Washington, D.C.